Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
Drugs in Dev.
News
Blog
Market Place
Login
Market Place

Looking for Intravenous Finished Formulations containing POLYSORBATE 80? Find Polysorbate 80 based pharmaceutical excipients on PharmaCompass.

Client Email

Product

Polysorbate 80
Polysorbate API
Polyoxyethylenesorbitan Monooleate (Tween 80)
Benzathine Penicillin G
Intravenous

EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

Contact Supplier

Bora Pharmaceuticals- Making success more certain.

Contact Supplier

Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

Contact Supplier

Minakem offers CDMO services for API & HPAPI, generics, regulatory expertise, track record performance & FDA & GMP certifications.

Contact Supplier

Axplora- The partner of choice for complex APIs.

Contact Supplier

Fareva is a one-stop-shop for API/HPAPI, OSD & Sterile products, is USFDA, EMA and PMDA-inspected and has multiple NDA & ANDA filings.

Contact Supplier

Polysorbate 80

CHEMISTRY

CHEMISTRY

Discover Molecule Insights

INACTIVE PHARMA INGREDIENTS

6 Suppliers, 6 USDMF, 3 CEP/COS, 15 Listed Suppliers, 1 Nanjing Bold Chemical, 1 Nanjing Well Pharmaceutical, 2 Actylis, 3 Gangwal Chemicals, 1 BASF, 1 Jai Radhe Sales, 6 Seppic

6 Suppliers
6 USDMF
3 CEP/COS
15 Listed Suppliers
1 Nanjing Bold Chemical
1 Nanjing Well Pharmaceutical
2 Actylis
3 Gangwal Chemicals
1 BASF
1 Jai Radhe Sales
6 Seppic

FINISHED DOSAGE FORMULATIONS

FDF Dossiers Suppliers, 120 FDA Dossiers

FDF Dossiers Suppliers
120 FDA Dossiers

EXCIPIENTS BY APPLICATIONS

10 Solubilizers, 5 Parenteral, 3 Emulsifying Agents, 3 Topical, 2 Surfactant & Foaming Agents, 2 Thickeners and Stabilizers, 2 Film Formers & Plasticizers, 1 Rheology Modifiers, 1 API Stability Enhancers, 1 Co-Processed Excipients, 1 Direct Compression

10 Solubilizers
5 Parenteral
3 Emulsifying Agents
3 Topical
2 Surfactant & Foaming Agents
2 Thickeners and Stabilizers
2 Film Formers & Plasticizers
1 Rheology Modifiers
1 API Stability Enhancers
1 Co-Processed Excipients
1 Direct Compression

MARKET PLACE

12 EXCIPIENTS

12 EXCIPIENTS

REF. STANDARDS & IMPURITIES

1 Others

1 Others

PharmaCompass

Xls

Filters

Reset all filters

Filters

FILTER :

filter Drug Reset all filters

12 All

01 1EMEND

02 4FOSAPREPITANT DIMEGLUMINE

03 1IMJUDO

04 1INFUVITE ADULT

05 1M.V.I. ADULT

06 1M.V.I. PEDIATRIC

07 1OPDUALAG

08 1TEMSIROLIMUS

09 1VARUBI

filter Application Number Reset all filters

12 All

01 118920

02 121163

03 121625

04 122023

05 1203153

06 1204015

07 1208399

08 1210689

09 1211624

10 1212309

11 1761234

12 1761289

filter Patent Reset all filters

12 All

01 11No

02 1Yes

List of Suppliers

01

ACCORD HLTHCARE

FNCE 2024

Not Confirmed

ACCORD HLTHCARE

FNCE 2024

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

TEMSIROLIMUS

Drug : TEMSIROLIMUS

Dosage Form : SOLUTION; INTRAVENOUS

Application Number : 203153

Country : US

Patented : No

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

02

ASTRAZENECA AB

TREMELIMUMAB-ACTL

FNCE 2024

Not Confirmed

ASTRAZENECA AB

FNCE 2024

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

TREMELIMUMAB-ACTL

Drug : IMJUDO

Dosage Form : INJECTABLE; INTRAVENOUS

Application Number : 761289

Country : US

Patented : No

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

03

BE PHARMS

FOSAPREPITANT DIMEGLUMINE

FNCE 2024

Not Confirmed

BE PHARMS

FNCE 2024

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

FOSAPREPITANT DIMEGLUMINE

Drug : FOSAPREPITANT DIMEGLUMINE

Dosage Form : POWDER; INTRAVENOUS

Application Number : 212309

Country : US

Patented : No

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

04

BRISTOL MYERS SQUIBB

NIVOLUMAB; RELATLIMAB-RMBW

FNCE 2024

Not Confirmed

BRISTOL MYERS SQUIBB

FNCE 2024

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

NIVOLUMAB; RELATLIMAB-RMBW

Drug : OPDUALAG

Dosage Form : SOLUTION; INTRAVENOUS

Application Number : 761234

Country : US

Patented : No

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

05

HOSPIRA

ASCORBIC ACID; BIOTIN; CYANOCOBALAMIN; DEXPANTHENOL; ERGOCALCIFEROL; FOLIC ACID; NIACINAMIDE; PYRIDOXINE HYDROCHLORIDE; RIBOFLAVIN 5-PHOSPHATE SODIUM; THIAMINE HYDROCHLORIDE; VITAMIN A; VITAMIN E; VITAMIN K

FNCE 2024

Not Confirmed

HOSPIRA

FNCE 2024

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

ASCORBIC ACID; BIOTIN; CYANOCOBALAMIN; DEXPANTHENOL; ERGOCALCIFEROL; FOLIC ACID; NIACINAMIDE; PYRIDOXINE HYDROCHLORIDE; RIBOFLAVIN 5-PHOSPHATE SODIUM; THIAMINE HYDROCHLORIDE; VITAMIN A; VITAMIN E; VITAMIN K

Drug : M.V.I. ADULT

Dosage Form : INJECTABLE; INTRAVENOUS

Application Number : 21625

Country : US

Patented : No

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

06

HOSPIRA

ASCORBIC ACID; BIOTIN; CYANOCOBALAMIN; DEXPANTHENOL; ERGOCALCIFEROL; FOLIC ACID; NIACINAMIDE; PHYTONADIONE; PYRIDOXINE HYDROCHLORIDE; RIBOFLAVIN 5-PHOSPHATE SODIUM; THIAMINE HYDROCHLORIDE; VITAMIN A; VITAMIN E

FNCE 2024

Not Confirmed

HOSPIRA

FNCE 2024

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

ASCORBIC ACID; BIOTIN; CYANOCOBALAMIN; DEXPANTHENOL; ERGOCALCIFEROL; FOLIC ACID; NIACINAMIDE; PHYTONADIONE; PYRIDOXINE HYDROCHLORIDE; RIBOFLAVIN 5-PHOSPHATE SODIUM; THIAMINE HYDROCHLORIDE; VITAMIN A; VITAMIN E

Drug : M.V.I. PEDIATRIC

Dosage Form : FOR SOLUTION; INTRAVENOUS

Application Number : 18920

Country : US

Patented : No

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

07

LUPIN LTD

FOSAPREPITANT DIMEGLUMINE

FNCE 2024

Not Confirmed

LUPIN LTD

FNCE 2024

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

FOSAPREPITANT DIMEGLUMINE

Drug : FOSAPREPITANT DIMEGLUMINE

Dosage Form : POWDER; INTRAVENOUS

Application Number : 210689

Country : US

Patented : No

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

08

MERCK AND CO INC

FOSAPREPITANT DIMEGLUMINE

FNCE 2024

Not Confirmed

MERCK AND CO INC

FNCE 2024

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

FOSAPREPITANT DIMEGLUMINE

Drug : EMEND

Dosage Form : POWDER; INTRAVENOUS

Application Number : 22023

Country : US

Patented : No

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

09

MYLAN LABS LTD

FOSAPREPITANT DIMEGLUMINE

FNCE 2024

Not Confirmed

MYLAN LABS LTD

FNCE 2024

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

FOSAPREPITANT DIMEGLUMINE

Drug : FOSAPREPITANT DIMEGLUMINE

Dosage Form : POWDER; INTRAVENOUS

Application Number : 204015

Country : US

Patented : No

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

10

GENEYORK PHARMS

FOSAPREPITANT DIMEGLUMINE

FNCE 2024

Not Confirmed

GENEYORK PHARMS

Country

FNCE 2024

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

FOSAPREPITANT DIMEGLUMINE

Drug : FOSAPREPITANT DIMEGLUMINE

Dosage Form : POWDER; INTRAVENOUS

Application Number : 211624

Country : US

Patented : No

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

1
2

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
LOOKING FOR A SUPPLIER?